SCHEMBL9717548

SCHEMBL9717548

CCCCCc1ccc(O)c(Cl)c1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 3/20 0.56
TP53 P04637 2/20 0.53
CYP3A4 P08684 2/20 0.53
ALOX5 P09917 2/20 0.53
MEN1 O00255 1/20 0.53
MAPT P10636 1/20 0.53
ALOX15 P16050 1/20 0.53
TSHR P16473 1/20 0.53
HTT P42858 1/20 0.53
KMT2A Q03164 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
BID P55957 3/20 0.42
MCL1 Q07820 3/20 0.42
BCL2L1 Q07817 2/20 0.42
BAK1 Q16611 2/20 0.42
KAT8 Q9H7Z6 2/20 0.42
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
EP300 Q09472 1/20 0.42
KAT2A Q92830 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9114093 0.86 PRKCI (0.47) TYRTP53CYP3A4ALOX5MEN1
SCHEMBL11866128 0.85 TYR (0.62) TYRTP53CYP3A4ALOX5MEN1
SCHEMBL11870059 0.84 TYR (0.60) TYRTP53CYP3A4ALOX5MEN1
SCHEMBL573936 0.83 BID (0.57) TYRTP53CYP3A4ALOX5MEN1
SCHEMBL15995366 0.81 BID (0.59) TYRTP53CYP3A4ALOX5MEN1
SCHEMBL574605 0.81 BID (0.59) TYRTP53CYP3A4ALOX5MEN1
SCHEMBL27462450 0.81 BID (0.59) TYRTP53CYP3A4ALOX5MEN1
SCHEMBL574395 0.81 BID (0.59) TYRTP53CYP3A4ALOX5MEN1
SCHEMBL70495 0.81 TYR (0.56) TYRTP53CYP3A4ALOX5MEN1
SCHEMBL9706286 0.79 TYR (0.54) TYRTP53CYP3A4ALOX5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0240256-B1 COMPOUNDS USEFUL IN TREATING SICKLE CELL ANEMIA MERCK & CO. INC. (US) 1992-04-29 EP disclosed
US-4731473-A Compounds useful in treating sickle cell anemia MERCK & CO., INC. (US) 1988-03-15 US disclosed
US-4731381-A Method of treating a person for sickle cell anemia MERCK & CO., INC. (US) 1988-03-15 US disclosed
US-4699926-A Compounds useful in treating sickle cell anemia MERCK & CO., INC. (US) 1987-10-13 US disclosed
EP-0240256-A2 Compounds useful in treating sickle cell anemia MERCK & CO. INC. (US) 1987-10-07 EP disclosed
EP-0023728-B1 ANISOTROPIC COMPOUNDS WITH NEGATIVE OR POSITIVE DIRECT ANISOTROPY AND LIMITED OPTICAL ANISOTROPY, AND LIQUID CRYSTAL MIXTURES CONTAINING THEM MERCK PATENT GmbH (DE) 1983-08-10 EP disclosed
US-4368135-A Anisotropic compounds with negative or positive DC-anisotropy and low optical anisotropy BBC, BROWN, BOVERI & COMPANY, LTD. (CH) 1983-01-11 US disclosed
EP-0023728-A1 Anisotropic compounds with negative or positive direct anisotropy and limited optical anisotropy, and liquid crystal mixtures containing them MERCK PATENT GmbH (DE) 1981-02-11 EP disclosed